Related Experiment Video
Updated: Aug 6, 2026
07:31
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Angiotensin-converting enzyme inhibitors and left ventricular remodeling: implications for nurses
1School of Nursing, University of Pittsburgh, USA.
Dimensions of Critical Care Nursing : DCCN
|January 20, 2000
Summary
Angiotensin-converting enzyme (ACE) inhibitors help manage heart remodeling after a heart attack. Critical care nurses are key in identifying patients who can benefit from this important ACE inhibitor treatment.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Left ventricular remodeling is a significant complication following myocardial infarction.
- Angiotensin-converting enzyme (ACE) inhibitors are established treatments for cardiovascular diseases.
Purpose of the Study:
- To highlight the role of critical care nurses in identifying patients who would benefit from ACE inhibitor therapy post-myocardial infarction.
- To emphasize the efficacy of ACE inhibitors in improving outcomes related to left ventricular remodeling.
Main Methods:
- Review of existing literature on ACE inhibitor use and left ventricular remodeling.
- Analysis of clinical indicators for patient selection.
Main Results:
- ACE inhibitors effectively mitigate adverse sequelae of left ventricular remodeling.
- Nurses are crucial in the early recognition of eligible patients.
Conclusions:
- ACE inhibitors are vital in managing post-myocardial infarction left ventricular remodeling.
- Enhanced recognition by critical care nurses can optimize patient outcomes through timely ACE inhibitor initiation.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:20Angina V: Nursing Management
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...